Skip to main content
Top
Published in: Journal of Natural Medicines 4/2009

01-10-2009 | Original Paper

Protection against cisplatin-induced nephrotoxicity in mice by Curcuma comosa Roxb. ethanol extract

Authors: Surawat Jariyawat, Pranida Kigpituck, Kanoknetr Suksen, Aporn Chuncharunee, Arusa Chaovanalikit, Pawinee Piyachaturawat

Published in: Journal of Natural Medicines | Issue 4/2009

Login to get access

Abstract

The protective effect of an ethanol extract of Curcuma comosa against cisplatin-induced renal toxicity in mice was studied. Adult male mice were pretreated for 4 days with the ethanol extract of C. comosa [100–200 mg/kg body weight (BW), orally (p.o.)] before injection of cisplatin (12.5 mg/kg BW, intraperitoneally (i.p.)). Five days later the mice were killed, and blood samples were collected to determine blood urea nitrogen (BUN) and plasma creatinine levels. Kidneys were examined histopathologically and levels of lipid peroxidation, gluthathione (GSH) content, and superoxide dismutase (SOD), gluthathione peroxidase (GPx), and catalase (CAT) activities were determined. Histological examinations revealed degenerative changes and tubular necrosis in mice treated with cisplatin, which were improved by pretreatment with C. comosa ethanol extract. Cisplatin raised BUN, creatinine, and kidney lipid peroxidation levels, and lowered kidney GSH content and levels of GPx, SOD, and CAT activities, all of which (except SOD and CAT) could be restored to normal values by pretreatment with 200 mg/kg BW of C. comosa ethanol extract. In addition, the ethanol extract of C. comosa and its isolated diarylheptanoid compound also exhibited radical scavenging activities. The results suggest that the ethanol extract of C. comosa exhibits effective protection against cisplatin-induced nephrotoxicity mediated through its antioxidant activity.
Literature
1.
go back to reference Schrier RW (2002) Cancer therapy and renal injury. J Clin Invest 110:743–745PubMed Schrier RW (2002) Cancer therapy and renal injury. J Clin Invest 110:743–745PubMed
2.
go back to reference Meyer KB, Medias NE (1994) Cisplatin nephrotoxicity. Miner Electrolyte Metab 20:201–213PubMed Meyer KB, Medias NE (1994) Cisplatin nephrotoxicity. Miner Electrolyte Metab 20:201–213PubMed
3.
go back to reference Chu G, Mantin R, Shen Y, Baskett G, Sussman H (1993) Massive cisplatin overdose by accidental substitution for carboplastin. Toxicity and management. Cancer 72:3707–3714PubMedCrossRef Chu G, Mantin R, Shen Y, Baskett G, Sussman H (1993) Massive cisplatin overdose by accidental substitution for carboplastin. Toxicity and management. Cancer 72:3707–3714PubMedCrossRef
4.
go back to reference Badary OA, Abdel-Maksoud S, Ahmed WA, Owieda GH (2005) Naringenin attenuates cisplatin nephrotoxicity in rats. Life Sci 76:2125–2135PubMedCrossRef Badary OA, Abdel-Maksoud S, Ahmed WA, Owieda GH (2005) Naringenin attenuates cisplatin nephrotoxicity in rats. Life Sci 76:2125–2135PubMedCrossRef
5.
go back to reference Ajith TA, Usha S, Nivitha V (2007) Ascorbic acid and alpha-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: a comparative study. Clin Chim Acta 375:82–86PubMedCrossRef Ajith TA, Usha S, Nivitha V (2007) Ascorbic acid and alpha-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: a comparative study. Clin Chim Acta 375:82–86PubMedCrossRef
6.
go back to reference Kuhad A, Pilkhwal S, Sharma S, Tirkey N, Chopra K (2007) Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity. J Agric Food Chem 55:10150–10155PubMedCrossRef Kuhad A, Pilkhwal S, Sharma S, Tirkey N, Chopra K (2007) Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity. J Agric Food Chem 55:10150–10155PubMedCrossRef
7.
go back to reference Menon VR, Sudheer AR (2007) Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 595:105–125PubMedCrossRef Menon VR, Sudheer AR (2007) Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 595:105–125PubMedCrossRef
8.
go back to reference Winuthayanon W, Suksen K, Boonchird C, Chuncharunee A, Ponglikitmongkol M, Suksamrarn A, Piyachaturawat P (2009) Estrogenic activity of diarylheptanoids from Curcuma comosa Roxb. requires metabolic activation. J Agric Food Chem 57:840–845PubMedCrossRef Winuthayanon W, Suksen K, Boonchird C, Chuncharunee A, Ponglikitmongkol M, Suksamrarn A, Piyachaturawat P (2009) Estrogenic activity of diarylheptanoids from Curcuma comosa Roxb. requires metabolic activation. J Agric Food Chem 57:840–845PubMedCrossRef
9.
go back to reference Jantaratnotai N, Utaisincharoen P, Piyachaturawat P, Chongthammakun S, Sanvarinda Y (2006) Inhibitory effect of Curcuma comosa on NO production and cytokine expression in LPS-activated microglia. Life Sci 78:571–577PubMedCrossRef Jantaratnotai N, Utaisincharoen P, Piyachaturawat P, Chongthammakun S, Sanvarinda Y (2006) Inhibitory effect of Curcuma comosa on NO production and cytokine expression in LPS-activated microglia. Life Sci 78:571–577PubMedCrossRef
10.
go back to reference Sodsai A, Piyachaturawat P, Sophasan S, Suksamrarn A, Vongsakul M (2007) Suppression by Curcuma comosa Roxb of pro-inflammatory cytokine secretion in phorbol-12-myristate-13-acetate stimulated human mononuclear cells. Int Immunopharmacol 7:524–531PubMedCrossRef Sodsai A, Piyachaturawat P, Sophasan S, Suksamrarn A, Vongsakul M (2007) Suppression by Curcuma comosa Roxb of pro-inflammatory cytokine secretion in phorbol-12-myristate-13-acetate stimulated human mononuclear cells. Int Immunopharmacol 7:524–531PubMedCrossRef
11.
go back to reference Suksamrarn A, Ponglikitmonkol M, Wongkrajang K, Chindaduang A, Kittidanairak S, Jankam A, Yingyoungnarongkul B, Kittipanumat N, Chokchaisiri R, Khetkam P, Piyachaturawat P (2008) Diarylheptanoids, a new phytoestrogens from the rhizomes of Curcuma comosa: isolation, chemical modification and estrogenic activity evaluation. Bioorg Med Chem 16:6891–6902PubMedCrossRef Suksamrarn A, Ponglikitmonkol M, Wongkrajang K, Chindaduang A, Kittidanairak S, Jankam A, Yingyoungnarongkul B, Kittipanumat N, Chokchaisiri R, Khetkam P, Piyachaturawat P (2008) Diarylheptanoids, a new phytoestrogens from the rhizomes of Curcuma comosa: isolation, chemical modification and estrogenic activity evaluation. Bioorg Med Chem 16:6891–6902PubMedCrossRef
12.
go back to reference Blois MS (1958) Antioxidant determination by the use of a stable free radical. Nature 181:1199–1200CrossRef Blois MS (1958) Antioxidant determination by the use of a stable free radical. Nature 181:1199–1200CrossRef
13.
go back to reference Thedorus PM, Helmut S (1981) Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol 77:373–382CrossRef Thedorus PM, Helmut S (1981) Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol 77:373–382CrossRef
14.
go back to reference Winterbourn CC, Hawkins RE, Brian M, Carrell RW (1975) The estimation of red cell superoxide dismutase activity. J Lab Clin Med 85:337–341PubMed Winterbourn CC, Hawkins RE, Brian M, Carrell RW (1975) The estimation of red cell superoxide dismutase activity. J Lab Clin Med 85:337–341PubMed
15.
16.
go back to reference Beers RF, Sizer IW (1952) A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195:133–140PubMed Beers RF, Sizer IW (1952) A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195:133–140PubMed
17.
go back to reference Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMedCrossRef Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMedCrossRef
18.
go back to reference Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed
19.
go back to reference Ito K, Sakakibara T, Handa J, Irie Y, Tsubosaki M, Matsuda A (1981) Safety test for cisplatin (NK801) (in Japanese). Kiso To Rinshou 15:5669–5686 Ito K, Sakakibara T, Handa J, Irie Y, Tsubosaki M, Matsuda A (1981) Safety test for cisplatin (NK801) (in Japanese). Kiso To Rinshou 15:5669–5686
20.
go back to reference Rao M, Praveen Rao PN, Kamath R, Rao MN (1999) Reduction of cisplatin-induced nephrotoxicity by cystone, a polyherbal ayurvedic preparation, in C57BL/6J mice bearing B16F1 melanoma without reducing its antitumor activity. J Ethnopharmacol 68:77–81PubMedCrossRef Rao M, Praveen Rao PN, Kamath R, Rao MN (1999) Reduction of cisplatin-induced nephrotoxicity by cystone, a polyherbal ayurvedic preparation, in C57BL/6J mice bearing B16F1 melanoma without reducing its antitumor activity. J Ethnopharmacol 68:77–81PubMedCrossRef
21.
go back to reference Lee S, Kim W, Moon SO, Sung MJ, Kim DH, Kang KP (2006) Rosiglitazone ameliorates cisplatin-induced renal injury in mice. Nephrol Dial Transplant 21:2096–2105PubMedCrossRef Lee S, Kim W, Moon SO, Sung MJ, Kim DH, Kang KP (2006) Rosiglitazone ameliorates cisplatin-induced renal injury in mice. Nephrol Dial Transplant 21:2096–2105PubMedCrossRef
22.
go back to reference Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, Karaoglu A (2005) Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology 212:116–123PubMedCrossRef Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, Karaoglu A (2005) Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology 212:116–123PubMedCrossRef
23.
go back to reference Sueishi K, Mishima K, Makino K, Itoh Y, Tsuruya K, Hirakata H (2002) Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats. Eur J Pharmacol 451:203–208PubMedCrossRef Sueishi K, Mishima K, Makino K, Itoh Y, Tsuruya K, Hirakata H (2002) Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats. Eur J Pharmacol 451:203–208PubMedCrossRef
24.
go back to reference Sadzuka Y, Shoji T, Takino Y (1992) Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation. Biochem Pharmacol 43:1872–1875PubMedCrossRef Sadzuka Y, Shoji T, Takino Y (1992) Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation. Biochem Pharmacol 43:1872–1875PubMedCrossRef
25.
go back to reference Ramesh G, Reeves WB (2002) TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110:743–745 Ramesh G, Reeves WB (2002) TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110:743–745
26.
go back to reference Tarloff JB, Lash LH (2005) Toxicology of the kidney, 3rd edn. CRC, Florida, pp 784–785 Tarloff JB, Lash LH (2005) Toxicology of the kidney, 3rd edn. CRC, Florida, pp 784–785
27.
go back to reference Sinha M, Manna P, Sil PC (2006) Aqueous extract of the bark of Terminalia arjuna plays a protective role against sodium-fluoride-induced hepatic and renal oxidative stress. J Nat Med 61:251–260CrossRef Sinha M, Manna P, Sil PC (2006) Aqueous extract of the bark of Terminalia arjuna plays a protective role against sodium-fluoride-induced hepatic and renal oxidative stress. J Nat Med 61:251–260CrossRef
28.
go back to reference Babu E, Gopalkrishnan VK, Sriganth NP, Gopalkrishnan R, Sakthisekharan D (1995) Cisplatin induced nephrotoxicity and the modulating effect of glutathione ester. Mol Cell Biochem 144:7–11PubMedCrossRef Babu E, Gopalkrishnan VK, Sriganth NP, Gopalkrishnan R, Sakthisekharan D (1995) Cisplatin induced nephrotoxicity and the modulating effect of glutathione ester. Mol Cell Biochem 144:7–11PubMedCrossRef
29.
go back to reference Dickey DT, Wu YJ, Muldoon LL, Neywelt EA (2005) Protection against cisplatin induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels. J Pharmacol Exp Ther 314:1052–1058PubMedCrossRef Dickey DT, Wu YJ, Muldoon LL, Neywelt EA (2005) Protection against cisplatin induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels. J Pharmacol Exp Ther 314:1052–1058PubMedCrossRef
30.
go back to reference Luo J, Tsuji T, Yasuda H, Sun Y, Fujigaki Y, Hishida A (2008) The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol Dial Transplant 23:2198–2205PubMedCrossRef Luo J, Tsuji T, Yasuda H, Sun Y, Fujigaki Y, Hishida A (2008) The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol Dial Transplant 23:2198–2205PubMedCrossRef
31.
go back to reference Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73:994–1007PubMedCrossRef Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73:994–1007PubMedCrossRef
32.
go back to reference Ramesh G, Kimball SR, Jefferson LS, Reeves WB (2007) Endotoxin and cisplatin synergistically stimulate TNF-α production by renal epithelial cells. Am J Physiol Renal Physiol 292:F812–F819PubMedCrossRef Ramesh G, Kimball SR, Jefferson LS, Reeves WB (2007) Endotoxin and cisplatin synergistically stimulate TNF-α production by renal epithelial cells. Am J Physiol Renal Physiol 292:F812–F819PubMedCrossRef
Metadata
Title
Protection against cisplatin-induced nephrotoxicity in mice by Curcuma comosa Roxb. ethanol extract
Authors
Surawat Jariyawat
Pranida Kigpituck
Kanoknetr Suksen
Aporn Chuncharunee
Arusa Chaovanalikit
Pawinee Piyachaturawat
Publication date
01-10-2009
Publisher
Springer Japan
Published in
Journal of Natural Medicines / Issue 4/2009
Print ISSN: 1340-3443
Electronic ISSN: 1861-0293
DOI
https://doi.org/10.1007/s11418-009-0345-5

Other articles of this Issue 4/2009

Journal of Natural Medicines 4/2009 Go to the issue